シンバイオ製薬株式会社 · SYMBIO PHARMACEUTICALS LIMITED
Last · —¥50.00-3.00 (-5.66%)live · yahoo · 4m ago
Market cap¥4.0B80.2M sh
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
¥50.00¥201.00
Volume815.9Ksession
| Revenue | ¥1.3B |
|---|---|
| Operating income | ¥-4.4B |
| Net income | ¥-4.8B |
| Operating margin | -339.6% |
| Net margin | -365.3% |
| Return on equity | -524.1% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-03-24
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~0.6 years
- Accumulated Deficit High — Accumulated deficit / equity 2945%
- Rd Intensity High — R&D/Revenue 252.2%
Upcoming earnings
7:30 AM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
0
Documents
FormReporting forFiledFlags